Restructuring helps Eckert & Ziegler increase profit
This article was originally published in Clinica
Executive Summary
Eckert & Ziegler, which develops weak sources of radiation used in treating cancer and heart disease, has recorded a rise in turnover during the first half of 2004 of 30% to Euros16.8m ($20.8m), compared with the same period last year. Turnover for the second quarter alone rose by 47% to Euros8.8m, the Berlin, Germany-based company announced.